HAE

美国血液技术
NYSE

实时行情|Nasdaq Last Sale

97.17
+5.55
+6.06%
交易中 15:12 04/02 EDT
开盘
92.81
昨收
91.62
最高
100.16
最低
91.73
成交量
28.92万
成交额
--
52周最高
140.36
52周最低
63.41
市值
48.87亿
市盈率(TTM)
63.43
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测HAE价格均价为144.43,最高价位165.00,最低价为130.00。

EPS

HAE 新闻

更多
  • Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
  • PR Newswire · 7小时前
  • Haemonetics Reports Purchase Of enicor, No Terms Disclosed
  • Benzinga · 8小时前
  • Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
  • PR Newswire · 2天前
  • Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
  • Benzinga · 2天前

所属板块

医疗设备、用品及经销
+1.61%
医疗设备和用品
+2.04%

热门股票

代码
价格
涨跌幅

HAE 简况

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.
展开

微牛提供Haemonetics Corporation(NYSE-HAE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的HAE股票新闻,以帮助您做出投资决策。